The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBBGI Global Infrastructure Regulatory News (BBGI)

Share Price Information for BBGI Global Infrastructure (BBGI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 140.40
Bid: 140.00
Ask: 140.40
Change: 2.20 (1.59%)
Spread: 0.40 (0.286%)
Open: 139.00
High: 140.40
Low: 138.00
Prev. Close: 138.20
BBGI Live PriceLast checked at -
BBGI SICAV S.A. is an Investment Trust

To provide a unique access to a global portfolio of high-quality infrastructure assets which generate stable, predictable cash flows over the life of government or government-backed contracts that typically extend to more than twenty years in length.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Financial close for new transportation PPP Project

26 Oct 2015 07:00

RNS Number : 3346D
BBGI SICAV S.A.
26 October 2015
 



26 October 2015

 

BBGI SICAV S.A.

(the "Company")

 

Financial close for new transportation PPP Project in Canada

 

BBGI SICAV S.A. (LSE ticker: BBGI) is pleased to announce that it has achieved financial close for the North Commuter Parkway PPP project, in Saskatoon, Saskatchewan, Canada.

 

BBGI is a 50% equity investor in the consortium that will design, build, finance, operate and maintain the infrastructure for a period of 30 years. The North Commuter Parkway Project involves the replacement of the 107-year-old Traffic Bridge in Saskatoon's downtown core as well as the development of a new six-lane bridge crossing the South Saskatchewan River in the City's north end and 8.3 kilometres of new arterial roadways.

 

Construction works relating to the project will be undertaken by Graham Construction. All construction obligations have been passed down to the builder. The concession term runs for 30 years plus a 3-year construction period. Payments under the project will all be availability based. BBGI expects to receive distributions throughout the concession period once the project becomes operational. BBGI's investment will be financed out of existing cash resources and borrowings under the credit facility.

 

Frank Schramm, Co-CEO said:

"We are excited to be involved in the development of this important infrastructure project. The project will improve travel efficiency within Saskatoon and will create jobs for local workers."

 

Duncan Ball, Co-CEO said:

"This transaction demonstrates our ability to grow our portfolio of infrastructure investments not only by acquiring operational projects but also by partnering with construction companies in consortium bids on primary market opportunities such as North Commuter Parkway. BBGI will continue to selectively pursue further growth opportunities in both new and existing assets."

 

For further information, please contact:

 

BBGI Management Team +352 263 479-1

Duncan Ball

Frank Schramm

 

 

BBGI owns a global portfolio of 37 infrastructure assets. These are PPP assets and are supported by contracted, public sector-backed revenue streams, with inflation-protection characteristics.

 

Further information about BBGI is available on its website at www.bb-gi.com *.

 

Any reference to the Company or BBGI refers also to its subsidiaries (where applicable).

 

* Neither the Company's website nor the content of any website accessible from hyperlinks on its website (or any other website) is (or is deemed to be) incorporated into, or forms (or is deemed to form) part of this announcement.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRLLFFVIDLEFIE
Date   Source Headline
8th May 20247:00 amRNSTransaction in Own Shares
1st May 20247:00 amRNSResult of AGM
25th Apr 202411:33 amRNSAnnual Financial Report for year ended 31-Dec-2023
9th Apr 20244:02 pmRNSDirector/PDMR Shareholding
4th Apr 20241:26 pmRNSDirector/PDMR Shareholding
4th Apr 202410:11 amRNSResults analysis from Kepler Trust Intelligence
2nd Apr 20243:59 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSPeriodic SFDR Disclosure
28th Mar 20247:00 amRNSAnnual Results - financial year ended 31-Dec-2023
27th Mar 20245:02 pmRNSNotice of AGM
14th Mar 20247:00 amRNSRetail Investor Results - Investor Meet Company
26th Feb 20247:00 amRNSDate of Annual Results
15th Feb 20247:00 amRNSSecond Interim Dividend
9th Feb 20247:00 amRNSGrant of Share Awards under LTIP
31st Jan 20243:59 pmRNSDirectorate Change
12th Dec 20232:48 pmRNSDirector/PDMR Shareholding
6th Dec 202310:00 amRNSDirector/PDMR Shareholding
6th Dec 20239:52 amRNSDirector/PDMR Shareholding
4th Dec 202310:23 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSKepler Trust Intelligence: New Research
28th Nov 20234:09 pmRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSDirectorate Change
27th Oct 20239:59 amRNSHolding(s) in Company
29th Sep 202310:02 amRNSTotal Voting Rights
29th Sep 20239:58 amRNSHolding(s) in Company
12th Sep 20233:26 pmRNSHalf-year Report
4th Sep 20237:00 amRNSSubstantial Completion Achieved On Highway 104
31st Aug 20237:00 amRNSDividend Declaration
31st Aug 20237:00 amRNSAdditional Listing
31st Aug 20237:00 amRNSHalf-year Report
16th Aug 20237:00 amRNSNotice of Interim Results and Results Presentation
13th Jul 20231:32 pmRNSHolding(s) in Company
30th Jun 20233:50 pmRNSDisclosure re SFDR
20th Jun 20234:50 pmRNSDirector/PDMR Shareholding
12th Jun 20237:50 amRNSPublication of 2022 ESG Report
1st Jun 20238:29 amRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNSKepler Trust Intelligence: New Research
31st May 20232:36 pmRNSTotal Voting Rights
26th May 202310:07 amRNSAdditional Listing
10th May 202310:55 amRNSAnnual Financial Report for year ended 31 Dec 2022
28th Apr 20233:13 pmRNSTotal Voting Rights
28th Apr 20231:46 pmRNSResult of AGM
26th Apr 20232:25 pmRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSAdditional Listing
30th Mar 20237:00 amRNSAnnual Results financial year ended 31-Dec-2022
28th Mar 20231:58 pmRNSNotice of AGM
3rd Mar 20234:34 pmRNSScrip Dividend Circular
16th Feb 20237:00 amRNSDividend Declaration
7th Feb 20237:00 amRNSDate of Annual Results
2nd Feb 20237:00 amRNSGrant of Share Awards under LTIP

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.